Detection of proteinase K-resistant prion protein and infectivity in mouse spleen by 2 weeks after scrapie agent inoculation - PubMed (original) (raw)
Detection of proteinase K-resistant prion protein and infectivity in mouse spleen by 2 weeks after scrapie agent inoculation
R E Race et al. J Gen Virol. 1992 Dec.
Abstract
The sequential accumulation of the protease-resistant form of the endogenous prion protein (PrP-res) was compared to levels of scrapie infectivity in the spleen and brain of scrapie-infected mice at various times after inoculation. In mouse spleen PrP-res was detected 1 week after inoculation, and increased 65-fold between 1 and 3 weeks post-inoculation and an additional 15-fold during the next 17 weeks. Infectivity in spleen reached a maximum plateau level by 3 weeks. In contrast, in mouse brain PrP-res was not detected until 8 weeks after inoculation and then increased 200-fold during the next 12 weeks. During this same time, infectivity increased approximately 10,000-fold. Therefore, in both spleen and brain of scrapie-infected mice accumulation of PrP-res and infectivity appear to be associated. However, it was not possible to show quantitative correlations between PrP-res detection and infectivity, perhaps owing to the inaccuracy of the infectivity assay.
Similar articles
- Normal and scrapie-associated forms of prion protein differ in their sensitivities to phospholipase and proteases in intact neuroblastoma cells.
Caughey B, Neary K, Buller R, Ernst D, Perry LL, Chesebro B, Race RE. Caughey B, et al. J Virol. 1990 Mar;64(3):1093-101. doi: 10.1128/JVI.64.3.1093-1101.1990. J Virol. 1990. PMID: 1968104 Free PMC article. - Effect of Sinc genotype, agent isolate and route of infection on the accumulation of protease-resistant PrP in non-central nervous system tissues during the development of murine scrapie.
Farquhar CF, Dornan J, Somerville RA, Tunstall AM, Hope J. Farquhar CF, et al. J Gen Virol. 1994 Mar;75 ( Pt 3):495-504. doi: 10.1099/0022-1317-75-3-495. J Gen Virol. 1994. PMID: 7907357 - Immunoaffinity purification and neutralization of scrapie prions.
Gabizon R, McKinley MP, Groth D, Westaway D, DeArmond SJ, Carlson GA, Prusiner SB. Gabizon R, et al. Prog Clin Biol Res. 1989;317:583-600. Prog Clin Biol Res. 1989. PMID: 2574871 Review. - Prion encephalopathies of animals and humans.
Prusiner SB. Prusiner SB. Dev Biol Stand. 1993;80:31-44. Dev Biol Stand. 1993. PMID: 8270114 Review.
Cited by
- Cellular biology of prion diseases.
Harris DA. Harris DA. Clin Microbiol Rev. 1999 Jul;12(3):429-44. doi: 10.1128/CMR.12.3.429. Clin Microbiol Rev. 1999. PMID: 10398674 Free PMC article. Review. - Recombinant prion protein refolded with lipid and RNA has the biochemical hallmarks of a prion but lacks in vivo infectivity.
Timmes AG, Moore RA, Fischer ER, Priola SA. Timmes AG, et al. PLoS One. 2013 Jul 30;8(7):e71081. doi: 10.1371/journal.pone.0071081. Print 2013. PLoS One. 2013. PMID: 23936256 Free PMC article. - Neuron-specific expression of a hamster prion protein minigene in transgenic mice induces susceptibility to hamster scrapie agent.
Race RE, Priola SA, Bessen RA, Ernst D, Dockter J, Rall GF, Mucke L, Chesebro B, Oldstone MB. Race RE, et al. Neuron. 1995 Nov;15(5):1183-91. doi: 10.1016/0896-6273(95)90105-1. Neuron. 1995. PMID: 7576660 Free PMC article. - Inhibition of scrapie-associated PrP accumulation. Probing the role of glycosaminoglycans in amyloidogenesis.
Priola SA, Caughey B. Priola SA, et al. Mol Neurobiol. 1994 Apr-Jun;8(2-3):113-20. doi: 10.1007/BF02780661. Mol Neurobiol. 1994. PMID: 7999307 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials